Manifestations, complications, and treatment of neurobrucellosis: a systematic review and meta-analysis

References

• Franco MP, Mulder M, Gilman RH, et al. Human brucellosis. Lancet Infect Dis. 2007;7(12):775–786.
   PubMed Web of Science ®Google Scholar
• Pappas G, Papadimitriou P, Akritidis N, et al. The new global map of human brucellosis. Lancet Infect Dis. 2006;6(2):91–99.
   PubMed Web of Science ®Google Scholar
• Buzgan T, Karahocagil MK, Irmak H, et al. Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature. Int J Infect Dis. 2010;14(6):e469-78–e478.
   PubMed Web of Science ®Google Scholar
• Rodríguez AM, Delpino MV, Miraglia MC, et al. Immune mediators of pathology in neurobrucellosis: from blood to central nervous system. Neuroscience. 2019;410:264–273.
   PubMed Web of Science ®Google Scholar
• Bashir R, Al-Kawi MZ, Harder EJ, et al. Nervous system brucellosis: diagnosis and treatment. Neurology. 1985;35(11):1576–1581.
   PubMed Web of Science ®Google Scholar
• Erdem H, Ulu-Kilic A, Kilic S, et al. Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study. Antimicrob Agents Chemother. 2012;56(3):1523–1528.
   PubMed Web of Science ®Google Scholar
• Miraglia MC, Rodriguez AM, Barrionuevo P, et al. Brucella abortus traverses brain microvascular endothelial cells using infected monocytes as a trojan horse. Front Cell Infect Microbiol. 2018;8:200.
   PubMed Web of Science ®Google Scholar
• Gul HC, Erdem H, Gorenek L, et al. Management of neurobrucellosis: an assessment of 11 cases. Intern Med. 2008;47(11):995–1001.
   PubMed Web of Science ®Google Scholar
• Haji-Abdolbagi M, Rasooli-Nejad M, Jafari S, et al. Clinical and laboratory findings in neurobrucellosis: review of 31 cases. Arch Iran Med. 2008;11(1):21–25.
   PubMed Web of Science ®Google Scholar
• Akdeniz H, Irmak H, Anlar O, et al. Central nervous system brucellosis: presentation, diagnosis and treatment. J Infect. 1998;36(3):297–301.
   PubMed Web of Science ®Google Scholar
• Asadipooya K, Dehghanian A, Omrani GH, et al. Short-course treatment in neurobrucellosis: a study in Iran. Neurol India. 2011;59(1):101–103.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and Meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–269,w64.
   PubMed Web of Science ®Google Scholar
• Gul HC, Erdem H, Bek S. Overview of neurobrucellosis: a pooled analysis of 187 cases. Int J Infect Dis. 2009;13(6):e339-43–e343.
   PubMed Web of Science ®Google Scholar
• Kizilkilic O, Calli C. Neurobrucellosis. Neuroimaging Clin N Am. 2011;21(4):927–937, ix.
   PubMed Web of Science ®Google Scholar
• Pappas G, Akritidis N, Christou L. Treatment of neurobrucellosis: what is known and what remains to be answered. Expert Rev anti Infect Ther. 2007;5(6):983–990.
   PubMed Web of Science ®Google Scholar
• Patra S, Kalwaje Eshwara V, Pai AR, et al. Evaluation of clinical, diagnostic features and therapeutic outcome of neurobrucellosis: a case series and review of literature. Int J Neurosci. 2021;1–11.
   PubMed Web of Science ®Google Scholar
• Guven T, Ugurlu K, Ergonul O, et al. Neurobrucellosis: clinical and diagnostic features. Clin Infect Dis. 2013;56(10):1407–1412.
   PubMed Web of Science ®Google Scholar
• Blettner M, Sauerbrei W, Schlehofer B, et al. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol. 1999;28(1):1–9.
   PubMed Web of Science ®Google Scholar
• Gagnier JK, Altman DG, Moher D, et al. The CARE guidelines: consensus-based clinical case reporting guideline development. Headache. 2013;53(10):1541–1547.
   PubMed Web of Science ®Google Scholar
• Dreyer NA, Bryant A, Velentgas P. The GRACE checklist: a validated assessment tool for high quality observational studies of comparative effectiveness. J Manag Care Spec Pharm. 2016;22(10):1107–1113.
   PubMed Web of Science ®Google Scholar
• Higgins JPT TJ, Chandler J, Cumpston M, et al. editor. Cochrane handbook for systematic reviews of interventions. Chichester (UK): John Wiley & Sons; 2019.
   Google Scholar
• von Hippel PT. The heterogeneity statistic I2 can be biased in small meta-analyses. BMC Med Res Methodol. 2015;15(1):35.
   PubMed Web of Science ®Google Scholar
• Borenstein M, Hedges L, Higgins J, et al. Comprehensive meta-analysis version 3. Englewood, NJ: CMA; 2013.
   Google Scholar
• Calik M, Iscan A, Gul M, et al. Severe neurobrucellosis in a young infant. Clin Neurol Neurosurg. 2012;114(7):1046–1048.
   PubMed Web of Science ®Google Scholar
• Tikare NV, Mantur BG, Bidari LH. Brucellar meningitis in an infant–evidence for human breast milk transmission. J Trop Pediatr. 2008;54(4):272–274.
   PubMed Web of Science ®Google Scholar
• Dadar M, Shahali Y, Alamian S. Isolation of Brucella melitensis biovar 1 from human milk confirms breastfeeding as a possible route for infant infection. Microb Pathog. 2021;157:104958.
   PubMed Web of Science ®Google Scholar
• Erdem H, Senbayrak S, Meriç K, et al. Cranial imaging findings in neurobrucellosis: results of Istanbul-3 study. Infection. 2016;44(5):623–631.
   PubMed Web of Science ®Google Scholar
• García Samartino C, Delpino MV, Pott Godoy C, et al. Brucella abortus induces the secretion of proinflammatory mediators from glial cells leading to astrocyte apoptosis. Am J Pathol. 2010;176(3):1323–1338.
   PubMed Web of Science ®Google Scholar
• Dong Y, Benveniste EN. Immune function of astrocytes. Glia. 2001;36(2):180–190.
   PubMed Web of Science ®Google Scholar
• Miraglia MC, Costa Franco MM, Rodriguez AM, et al. Glial cell-elicited activation of brain microvasculature in response to Brucella abortus infection requires ASC inflammasome-dependent IL-1β production. J Immunol. 2016;196(9):3794–3805.
   PubMed Web of Science ®Google Scholar
• Rosenzweig HL, Planck SR, Rosenbaum JT. NLRs in immune privileged sites. Curr Opin Pharmacol. 2011;11(4):423–428.
   PubMed Web of Science ®Google Scholar
• Rodríguez AM, Delpino MV, Miraglia MC, et al. Brucella abortus-activated microglia induce neuronal death through primary phagocytosis. Glia. 2017;65(7):1137–1151.
   PubMed Web of Science ®Google Scholar
• Bains R, Dahhan T, Belzowski A, et al. An interesting case of neurobrucellosis mimicking neuropsychiatric lupus. Case Rep Rheumatol. 2018;2018:9793535.
   PubMedGoogle Scholar
• Miyares FR, Deleu D, ElShafie SS, et al. Irreversible papillitis and ophthalmoparesis as a presenting manifestation of neurobrucellosis. Clin Neurol Neurosurg. 2007;109(5):439–441.
   PubMed Web of Science ®Google Scholar
• Sudhamshu KC, Kumar AR, Dias M, et al. Neurobrucellosis infection of ventriculoperitoneal shunt presenting as peritonitis. Indian J Pediatr. 2016;83(9):1024.
   PubMed Web of Science ®Google Scholar
• Al-Otaibi A, Almuneef M, Shaalan MA. Brucella melitensis infection of ventriculo-peritoneal shunt: a form of neurobrucellosis manifested as gastrointestinal symptoms. J Infect Public Health. 2014;7(1):62–65.
   PubMed Web of Science ®Google Scholar
• Abdinia B, Barzegar M, Malaki M, et al. Association of Brucella meningoencephalitis with cerebrospinal fluid shunt in a child: a case report. Iran J Child Neurol. 2013;7(1):35–38.
   PubMedGoogle Scholar
• Locutura J, Lorenzo JF, Miján A, et al. Non-simultaneous Brucella peritonitis and meningitis in a patient with a ventriculoperitoneal shunt. Eur J Clin Microbiol Infect Dis. 1998;17(5):361–362.
   PubMed Web of Science ®Google Scholar
• Al-Qarhi R, Al-Dabbagh M. Brucella shunt infection complicated by peritonitis: case report and review of the literature. Infect Dis Rep. 2021;13(2):367–376.
   PubMed Web of Science ®Google Scholar
• Covrig RC, Petridou J, Knappe UJ. Atypical presentation of neurobrucellosis as infection of ventriculoperitoneal shunt. J Neurol Surg A Cent Eur Neurosurg. 2021;82(2):186–188.
   PubMedGoogle Scholar